For the year ending 2025-12-31, ACXP has $7,689,535 in assets. $2,420,943 in debts.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash | 7,556,100 | |||
| Other receivable | 48,417 | |||
| Prepaid expenses | 85,018 | |||
| Total assets | 7,689,535 | |||
| Accounts payable and accrued expenses | 2,420,943 | |||
| Total current liabilities | 2,420,943 | |||
| Total liabilities | 2,420,943 | |||
| Common stock 0.001 par value, 250,000,000 shares authorized, 2,348,113 shares issued and outstanding at december 31, 2025 and 200,000,000 shares authorized, 851,534 shares issued and outstanding at december 31, 2024 | 2,348 | |||
| Additional paid-in capital | 80,554,738 | |||
| Accumulated deficit | -75,288,494 | |||
| Total shareholders' equity | 5,268,592 | |||
| Total liabilities and shareholders' equity | 7,689,535 | |||
Acurx Pharmaceuticals, Inc. (ACXP)
Acurx Pharmaceuticals, Inc. (ACXP)